Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Fusion Pharmaceuticals Inc.

2024 R-1 Main Residency Match results released

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Valeo Pharma Inc.

Nexstim Plc: Managers’ Transactions, Forss

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

Nexstim Plc: Managers’ Transactions, Hildén

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients

Read more ››
By: GlobeNewswire - 25 Apr 2024

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Kymera Therapeutics Inc.

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Morphic Therapeutic, Inc.

TELA Bio to Announce First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  TELA Bio, Inc

Microbix Collaborator Introduces New Lab Accreditation Program

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Microbix Biosystems Inc.

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nucleome Therapeutics Limited

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  BioXcel Therapeutics, Inc.

Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  OptiNose US Inc.

Sweetwater Brewing Unveils Modern Rebrand

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Tilray Inc.

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Eyenovia, Inc.

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Hookipa Pharma Inc.

Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑